Notably, sulodexide prevented hyperglycemia-induced overexpression of NOX4 and NOX5, suggesting that this may be a mechanism that prevents excessive ROS generation and endothelial dysfunction. The gene discussed is NOX5; the disease is Hyperglycemia.